These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39000203)

  • 1. CHI3L1 as a Prognostic Biomarker and Therapeutic Target in Glioma.
    Zhou J; Zhao D; Tan H; Lan J; Bao Y
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial Membrane Protein-3 and Chitinase-3-like Protein-1 as New Prognostic Predictors of Glioma, a Two-Gene Study.
    Shen K; Zhu J; Zhou S; Jin X; Zhai W; Sun L; Wu J; Yu Z
    Curr Oncol; 2023 Sep; 30(10):8686-8702. PubMed ID: 37887529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
    Lvu W; Fei X; Chen C; Zhang B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPHB2 as a key mediator of glioma progression: Insights from microenvironmental receptor ligand-related prognostic gene signature.
    Tan L; Zhou J; Nie Z; Li D; Wang B
    Genomics; 2024 May; 116(3):110799. PubMed ID: 38286348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
    Yang A; Wang X; Hu Y; Shang C; Hong Y
    Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHI3L1 predicted in malignant entities is associated with glioblastoma immune microenvironment.
    Li F; Qi B; Yang L; Wang B; Gao L; Zhao M; Luo L
    Clin Immunol; 2022 Dec; 245():109158. PubMed ID: 36244672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.
    Ku BM; Lee YK; Ryu J; Jeong JY; Choi J; Eun KM; Shin HY; Kim DG; Hwang EM; Yoo JC; Park JY; Roh GS; Kim HJ; Cho GJ; Choi WS; Paek SH; Kang SS
    Int J Cancer; 2011 Mar; 128(6):1316-26. PubMed ID: 20506295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma.
    Gao YF; Zhu T; Mao CX; Liu ZX; Wang ZB; Mao XY; Li L; Yin JY; Zhou HH; Liu ZQ
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
    Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ
    Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitinase 3 like-1 activates the Akt pathway, inducing NF-κB-dependent release of pro-inflammatory cytokines and promoting the proliferative ability in nasopharyngeal carcinoma cells.
    Li D; Fan G; Zhou Y
    Cytokine; 2024 Jul; 179():156631. PubMed ID: 38710115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDCL3 as a prognostic factor and associated with the VEGF signaling pathway in glioma.
    Yang B; Zheng G; Lu F
    J Gene Med; 2024 Aug; 26(8):e3724. PubMed ID: 39107869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.